PROFOUND MEDICAL CORP. Revenue
PROFOUND MEDICAL CORP. (PROF) reported Revenue of $2.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-08-06
- PROFOUND MEDICAL CORP. revenues for the quarter ending 2026-06-30 was $2.48M, a 12.30% increase year-over-year.
- PROFOUND MEDICAL CORP. revenues for the quarter ending 2026-03-31 was $5.34M, a 103.62% increase year-over-year.
- PROFOUND MEDICAL CORP. revenues for the quarter ending 2025-12-31 was $5.98M, a 43.13% increase year-over-year.
- PROFOUND MEDICAL CORP. revenues for the quarter ending 2025-09-30 was $5.29M, a 86.76% increase year-over-year.
- PROFOUND MEDICAL CORP. revenues for fiscal 2025 was $16.10M, a 50.73% increase from fiscal 2024.
- PROFOUND MEDICAL CORP. revenues for fiscal 2024 was $10.68M, a 48.35% increase from fiscal 2023.
- PROFOUND MEDICAL CORP. revenues for fiscal 2023 was $7.20M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.48M 10-Q · filed 2026-08-06 | $7.82M 10-Q · filed 2026-08-06 | $13.80M derived: sum of 3 quarters · filed 2026-08-06 | $19.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $5.34M 10-Q · filed 2026-05-07 | $11.31M derived: sum of 2 quarters · filed 2026-05-07 | $16.60M derived: sum of 3 quarters · filed 2026-05-07 | $18.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $11.27M derived: sum of 2 quarters · filed 2026-03-05 | $13.48M derived: sum of 3 quarters · filed 2026-08-06 | $16.10M 10-K · filed 2026-03-05 |
| 2025-09-30 | $5.29M 10-Q · filed 2025-11-13 | $7.50M derived: sum of 2 quarters · filed 2026-08-06 | $10.12M 10-Q · filed 2025-11-13 | $14.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.21M 10-Q · filed 2026-08-06 | $4.83M 10-Q · filed 2026-08-06 | $9.01M derived: sum of 3 quarters · filed 2026-08-06 | $11.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.62M 10-Q · filed 2026-05-07 | $6.80M derived: sum of 2 quarters · filed 2026-05-07 | $9.63M derived: sum of 3 quarters · filed 2026-05-07 | $11.86M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.01M derived: sum of 2 quarters · filed 2026-03-05 | $9.24M derived: sum of 3 quarters · filed 2026-03-05 | $10.68M 10-K · filed 2026-03-05 |
| 2024-09-30 | $2.83M 10-Q · filed 2025-11-13 | $5.07M derived: sum of 2 quarters · filed 2025-11-13 | $6.50M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $2.23M 10-Q · filed 2025-08-14 | $3.67M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $1.44M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $7.20M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |